These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 24726808)
1. Novel synthesis of nitro-quinoxalinone derivatives as aldose reductase inhibitors. Hussain S; Parveen S; Qin X; Hao X; Zhang S; Chen X; Zhu C; Ma B Bioorg Med Chem Lett; 2014 May; 24(9):2086-9. PubMed ID: 24726808 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors. Hussain S; Parveen S; Hao X; Zhang S; Wang W; Qin X; Yang Y; Chen X; Zhu S; Zhu C; Ma B Eur J Med Chem; 2014 Jun; 80():383-92. PubMed ID: 24793885 [TBL] [Abstract][Full Text] [Related]
3. Phenolic 4-hydroxy and 3,5-dihydroxy derivatives of 3-phenoxyquinoxalin-2(1H)-one as potent aldose reductase inhibitors with antioxidant activity. Zou Y; Qin X; Hao X; Zhang W; Yang S; Yang Y; Han Z; Ma B; Zhu C Bioorg Med Chem Lett; 2015 Sep; 25(18):3924-7. PubMed ID: 26227780 [TBL] [Abstract][Full Text] [Related]
4. Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors. Ji Y; Chen X; Chen H; Zhang X; Fan Z; Xie L; Ma B; Zhu C Bioorg Med Chem; 2019 Apr; 27(8):1658-1669. PubMed ID: 30858026 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors. Wu B; Yang Y; Qin X; Zhang S; Jing C; Zhu C; Ma B ChemMedChem; 2013 Dec; 8(12):1913-7. PubMed ID: 24115741 [TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones. Qin X; Hao X; Han H; Zhu S; Yang Y; Wu B; Hussain S; Parveen S; Jing C; Ma B; Zhu C J Med Chem; 2015 Feb; 58(3):1254-67. PubMed ID: 25602762 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity. Hao X; Han Z; Li Y; Li C; Wang X; Zhang X; Yang Q; Ma B; Zhu C Bioorg Med Chem Lett; 2017 Feb; 27(4):887-892. PubMed ID: 28109789 [TBL] [Abstract][Full Text] [Related]
8. Identification of quinoxalin-2(1 Hao X; Qin X; Zhang X; Ma B; Qi G; Yu T; Han Z; Zhu C Future Med Chem; 2019 Dec; 11(23):2989-3004. PubMed ID: 31659919 [No Abstract] [Full Text] [Related]
9. An efficient synthesis of quinoxalinone derivatives as potent inhibitors of aldose reductase. Yang Y; Zhang S; Wu B; Ma M; Chen X; Qin X; He M; Hussain S; Jing C; Ma B; Zhu C ChemMedChem; 2012 May; 7(5):823-35. PubMed ID: 22416050 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold. Chen X; Yang Y; Ma B; Zhang S; He M; Gui D; Hussain S; Jing C; Zhu C; Yu Q; Liu Y Eur J Med Chem; 2011 May; 46(5):1536-44. PubMed ID: 21367494 [TBL] [Abstract][Full Text] [Related]
11. 1,2-Benzothiazine 1,1-dioxide carboxylate derivatives as novel potent inhibitors of aldose reductase. Chen X; Zhang S; Yang Y; Hussain S; He M; Gui D; Ma B; Jing C; Qiao Z; Zhu C; Yu Q Bioorg Med Chem; 2011 Dec; 19(23):7262-9. PubMed ID: 22036211 [TBL] [Abstract][Full Text] [Related]
13. Discovery of new inhibitors of aldose reductase from molecular docking and database screening. Rastelli G; Ferrari AM; Costantino L; Gamberini MC Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806 [TBL] [Abstract][Full Text] [Related]
14. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives. Celestina SK; Sundaram K; Ravi S Bioorg Chem; 2020 Apr; 97():103640. PubMed ID: 32086051 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of aldose reductase inhibition and docking studies of 6'-nitro and 6',6''-dinitrorosmarinic acids. Koukoulitsa C; Bailly F; Pegklidou K; Demopoulos VJ; Cotelle P Eur J Med Chem; 2010 Apr; 45(4):1663-6. PubMed ID: 20071057 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships and molecular modelling of new 5-arylidene-4-thiazolidinone derivatives as aldose reductase inhibitors and potential anti-inflammatory agents. Maccari R; Vitale RM; Ottanà R; Rocchiccioli M; Marrazzo A; Cardile V; Graziano AC; Amodeo P; Mura U; Del Corso A Eur J Med Chem; 2014 Jun; 81():1-14. PubMed ID: 24819954 [TBL] [Abstract][Full Text] [Related]
17. Acetic acid derivatives of 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide as a novel class of potent aldose reductase inhibitors. Chen X; Zhu C; Guo F; Qiu X; Yang Y; Zhang S; He M; Parveen S; Jing C; Li Y; Ma B J Med Chem; 2010 Dec; 53(23):8330-44. PubMed ID: 21062005 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs). Reddy TN; Ravinder M; Bagul P; Ravikanti K; Bagul C; Nanubolu JB; Srinivas K; Banerjee SK; Rao VJ Eur J Med Chem; 2014 Jan; 71():53-66. PubMed ID: 24275248 [TBL] [Abstract][Full Text] [Related]
20. Green fluorescent protein chromophore derivatives as a new class of aldose reductase inhibitors. Saito R; Hoshi M; Kato A; Ishikawa C; Komatsu T Eur J Med Chem; 2017 Jan; 125():965-974. PubMed ID: 27769036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]